ALLO-316
ALLO-316-101
Phase 1 gene_therapy active
Quick answer
ALLO-316 for Advanced/Metastatic Clear Cell Renal Cell Carcinoma is a Phase 1 program (gene_therapy) at Allogene Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Allogene Therapeutics
- Indication
- Advanced/Metastatic Clear Cell Renal Cell Carcinoma
- Phase
- Phase 1
- Modality
- gene_therapy
- Status
- active